Bridgefront Capital’s Rentokil RTO Stock Holding History

Bridgefront Capital’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,139	Closed	-$215K	–	636
2024 Q1	$215K	Buy	+7,139	New	+$198K	0.16%	300

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bridgefront Capital's RTO Position: Q2 2024 in Review

Bridgefront Capital sold out of Rentokil (RTO) in Q2 2024, closing a stake of 7,139 shares — an estimated $215K sold.

Bridgefront Capital first reported a position in RTO in Q1 2024 and held it in 1 quarter. The position peaked at $215K in Q1 2024. 232 funds tracked by Wall St. Rank hold RTO as of Q2 2024.

Bridgefront Capital reported no remaining Rentokil position as of Q2 2024 after selling out during the quarter.
Bridgefront Capital sold 7,139 Rentokil shares in Q2 2024, an estimated $215K.
Bridgefront Capital first reported a position in Rentokil in Q1 2024 and held it in 1 quarter.
Bridgefront Capital's Rentokil position peaked at $215K in Q1 2024.
232 funds tracked by Wall St. Rank held Rentokil as of Q2 2024.

Based on Bridgefront Capital's 13F filing for Q2 2024, filed 14 Aug 2024.